Public Policy Letters, Statements, Legal Briefs, & Other Responses
← Back to all Letters & Statements
-
ACMG Comments on FDA Plausible Mechanism Draft Guidance
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities